WELL Health Technologies (TSE:WELL) Given New C$7.50 Price Target at Royal Bank of Canada

WELL Health Technologies (TSE:WELL) had its price target lowered by Royal Bank of Canada from C$8.50 to C$7.50 in a research note released on Monday,BayStreet.CA reports. Royal Bank of Canada currently has an outperform rating on the stock.

Other equities analysts have also recently issued research reports about the company. TD Securities boosted their target price on WELL Health Technologies from C$8.00 to C$8.50 in a research report on Tuesday, December 17th. Ventum Financial raised their target price on shares of WELL Health Technologies from C$7.50 to C$8.00 in a report on Thursday, January 30th. CIBC boosted their price target on WELL Health Technologies from C$5.25 to C$7.00 in a report on Friday, December 13th. Scotiabank upped their price objective on shares of WELL Health Technologies from C$6.00 to C$7.00 in a research note on Monday, December 16th. Finally, Haywood Securities upped their target price on WELL Health Technologies from C$8.00 to C$10.00 in a research note on Friday, December 13th.

WELL Health Technologies Price Performance

Shares of TSE WELL opened at C$4.14 on Monday. The stock’s 50-day simple moving average is C$5.76 and its 200-day simple moving average is C$5.57. The company has a debt-to-equity ratio of 46.79, a quick ratio of 1.02 and a current ratio of 1.14. The firm has a market capitalization of C$1.03 billion, a PE ratio of 14.03, a price-to-earnings-growth ratio of -1.93 and a beta of 1.20. WELL Health Technologies has a fifty-two week low of C$3.41 and a fifty-two week high of C$7.36.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.